Artisan Partners
SMMT icon

Artisan Partners’s Summit Therapeutics SMMT Stock Holding History

Artisan Partners’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-89,373
Closed -$1.72M – 379
2025
Q1 		$1.72M Sell
89,373
-5,387
-6% -$108K ﹤0.01% 331
2024
Q4 		$1.69M Buy
+94,760
New +$1.84M ﹤0.01% 348

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Artisan Partners's SMMT Position: Q2 2025 in Review

Artisan Partners sold out of Summit Therapeutics (SMMT) in Q2 2025, closing a stake of 89,373 shares — an estimated $1.72M sold.

Artisan Partners first reported a position in SMMT in Q4 2024 and held it in 2 quarters. The position peaked at $1.72M in Q1 2025. 238 funds tracked by Wall St. Rank hold SMMT as of Q2 2025.

  • Artisan Partners reported no remaining Summit Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Artisan Partners sold 89,373 Summit Therapeutics shares in Q2 2025, an estimated $1.72M.
  • Artisan Partners first reported a position in Summit Therapeutics in Q4 2024 and held it in 2 quarters.
  • Artisan Partners's Summit Therapeutics position peaked at $1.72M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2025.

Based on Artisan Partners's 13F filing for Q2 2025, filed 12 Aug 2025.